743 results on '"Legnani C"'
Search Results
2. Low drug levels and thrombotic complications in high‐risk atrial fibrillation patients treated with direct oral anticoagulants
3. International collaborative study for the calibration of proposed International Standards for thromboplastin, rabbit, plain, and for thromboplastin, recombinant, human, plain
4. PB0473 VTE Outcomes in Patients Treated with Direct Oral Anticoagulants and Concurrent Antiepileptic Drugs: Data from the START2 and the RIETE
5. Reduced graphene oxide prepared at low temperature thermal treatment as transparent conductors for organic electronic applications
6. External validation of the DASH prediction rule: a retrospective cohort study
7. Variability of cut‐off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study
8. Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study
9. The use of Focused Ion Beam to Build Nanodevices with Graphitic Structures
10. White OLED based on a temperature sensitive Eu3+/Tb3+ β-diketonate complex
11. Interlaboratory variability in the measurement of direct oral anticoagulants: results from the external quality assessment scheme
12. Obstetric implications of fetal inherited thrombophilia in thrombophilic women
13. D-dimer and reduced dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study
14. Determination of dopant concentration in co-deposited organic thin films by using RBS and X-ray fluorescence combined techniques
15. The Wells rule and D‐dimer for the diagnosis of isolated distal deep vein thrombosis
16. Ultraviolet photodegradation of tris(8-hydroxy-quinolinate) aluminum (Alq3) thin films studied by electron and laser stimulated desorption
17. Mortality and inherited thrombophilia: results from the European Prospective Cohort on Thrombophilia
18. Normalization of Plasma Antithrombin Activity in Patients Requiring Hemodynamic and/or Respiratory Support has Anti-inflammatory Properties Related to Survival
19. Comparison between different D-Dimer cutoff values to assess the individual risk of recurrent venous thromboembolism: analysis of results obtained in the DULCIS study
20. Sex, age and normal post‐anticoagulation D‐dimer as risk factors for recurrence after idiopathic venous thromboembolism in the Prolong study extension
21. D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study
22. Clinical course of high‐risk patients diagnosed with antiphospholipid syndrome
23. Residual Venous Obstruction, alone and in Combination with D-Dimer, as a Risk Factor for Recurrence after Anticoagulation Withdrawal following a First Idiopathic Deep Vein Thrombosis in the Prolong Study
24. Improved multilayer OLED architecture using evolutionary genetic algorithm
25. Transparent thermally stable poly(etherimide) film as flexible substrate for OLEDs
26. The risk of a first and a recurrent venous thrombosis associated with an elevated D-dimer level and an elevated thrombin potential: results of the THE-VTE study: comment
27. Evaluation of a chemiluminescent immunoassay, the HemosIL AcuStar D–Dimer, in outpatients with clinically suspected deep venous thrombosis
28. G20210A Prothrombin Mutation and Critical Limb Ischaemia in Patients with Peripheral Arterial Disease
29. Novel electroluminescent devices containing Eu 3+-(2-acyl-1,3-indandionate) complexes with TPPO ligand
30. High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism
31. Electroluminescent devices based on rare-earth tetrakis β-diketonate complexes
32. Bacterial cellulose membrane as flexible substrate for organic light emitting devices
33. D-dimer use for deep venous thrombosis exclusion in elderly patients: a comparative analysis of three different approaches to establish cut-off values for an assay with results expressed in D-dimer units
34. D-dimer for the diagnosis of symptomatic upper extremity deep vein thrombosis: PHV01
35. Indium tin oxide films prepared via wet chemical route
36. Electroluminescence of zinc oxide thin-films prepared via polymeric precursor and via sol–gel methods
37. Monolayer of silica nanospheres assembled onto ITO-coated glass substrates by spin-coating
38. The influence of the thrombotic burden on D-dimer plasma levels in acute symptomatic deep vein thrombosis of the lower limbs: PB 3.64–6
39. D-dimer, factor VIII, and thrombotic burden during the acute phase of leg deep venous thrombosis and early signs and symptoms of post-thrombotic syndrome: PB 2.74–3
40. Factors associated with early and late hypercoagulability after stopping anticoagulation for idiopathic venous thromboembolism: PB 2.71–1
41. Two years outcome and features of isolated distal vein thrombosis: PB 2.71–6
42. Endothelial activation in patients with superficial vein thrombosis (SVT) of the lower limbs: PB 2.31–4
43. Not all factor V Leiden or prothrombin G20210A mutations are equal: results from a retrospective cohort family study: PA 4.18–5
44. D-dimer and ultrasound in combination italian study (DULCIS) to establish the optimal duration of anticoagulation for venous thromboembolism on behalf of the DULCIS investigators: OC 12.4
45. The use of Focused Ion Beam to Build Nanodevices with Graphitic Structures
46. Prothrombin A19911G polymorphism and the risk of venous thromboembolism
47. Low voltage electroluminescence of terbium- and thulium-doped zinc oxide films
48. Electroluminescence of a device based on europium β-diketonate with phosphine oxide complex
49. Organic light emitting diodes based on dipyridamole drug
50. White OLED using β-diketones rare earth binuclear complex as emitting layer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.